AN INTERLEUKIN-6-INDUCED ACUTE-PHASE RESPONSE DOES NOT CONFER PROTECTION AGAINST LIPOPOLYSACCHARIDE LETHALITY

Citation
Se. Bucklin et al., AN INTERLEUKIN-6-INDUCED ACUTE-PHASE RESPONSE DOES NOT CONFER PROTECTION AGAINST LIPOPOLYSACCHARIDE LETHALITY, Infection and immunity, 61(8), 1993, pp. 3184-3189
Citations number
25
Categorie Soggetti
Immunology,"Infectious Diseases
Journal title
ISSN journal
00199567
Volume
61
Issue
8
Year of publication
1993
Pages
3184 - 3189
Database
ISI
SICI code
0019-9567(1993)61:8<3184:AIARDN>2.0.ZU;2-K
Abstract
Lipopolysaccharide (LPS), a component of gram-negative bacterial outer cell walls, can stimulate lymphoreticular cells to produce cytokines such as tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1), and IL-6. One of these proinflammatory cytokines, IL-6, induces hepat ic synthesis of a class of proteins termed acute-phase proteins. D-Gal actosamine inhibits acute-phase protein synthesis and concurrently sen sitizes mice to a lethal dose of LPS approximately 10,000-fold. From t hese observations, we hypothesized that the acute-phase response may s erve as a defense mechanism for protection of the host against the del eterious effects of LPS. To test this hypothesis, murine recombinant I L-6 (mrIL-6) was used to induce an acute-phase response prior to a let hal LPS challenge in both D-galactosamine-treated and normal mice. Ind uction of the acute-phase response by mrIL-6 was quantitated by measur ing the concentrations of fibrinogen and complement component C3, two well-characterized acute-phase proteins, in the circulation. The effec t of acute-phase and normal serum on TNF-alpha release by peritoneal m acrophages stimulated with LPS in vitro was also examined. The results of these studies confirmed the induction of the acute-phase response by mrIL-6, as reflected in an approximate doubling in circulating leve ls of fibrinogen and C3. However, when either D-galactosamine-sensitiz ed or normal mice were challenged with a lethal dose of LPS at various times after mrIL-6 administration, the acute-phase response induced b y mrIL-6 did not alter either cumulative lethality or the kinetics of lethality. Additionally, compared with normal serum, acute-phase serum did not affect TNF-alpha release by peritoneal macrophages following LPS-mediated stimulation in vitro. Collectively, these studies would n ot support a dominant role for an IL-6-mediated acute-phase response a s contributing to the resistance of normal mice compared with D-galact osamine-sensitized mice in LPS-induced lethal toxicity.